Preoperative antiplatelet strategies and coronary artery bypass graft outcomes: bleeding and cardiovascular events in 41,696 patients with acute coronary syndrome
Rui Liu, Ze Zhang, Lili An, Meice Tian, Rui Liu, Chun Liu, Xiumeng Hua, Han Han, Xianqiang Wang · 2026
Read Preoperative antiplatelet strategies and coronary artery bypass graft outcomes: bleeding and cardiovascular events in 41,696 patients with acute coronary syndrome by Rui Liu, Ze Zhang, Lili An, Meice Tian, Rui Liu, Chun Liu, Xiumeng Hua, Han Han, Xianqiang Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13655894.txt.
Description
Liu and co-authors study when patients should stop blood-thinning drugs before bypass surgery on the heart. Stopping too late raises bleeding during surgery. Stopping too early raises the risk of a heart event while waiting. Both harms matter in urgent cases.
The team drew on a large surgical database with over forty-one thousand patients treated between 2009 and 2019. All had acute heart syndromes and bypass surgery alone. About one quarter kept taking the drugs until within a week of surgery. The rest stopped earlier. The study compared major bleeding and heart events between the two paths. Its size lets it detect gaps smaller studies miss. The results can help surgeons set a stopping rule that trades the two risks evenly.
Catalog record
| CREATOR | Rui Liu, Ze Zhang, Lili An, Meice Tian, Rui Liu, Chun Liu, Xiumeng Hua, Han Han, Xianqiang Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |